Last reviewed · How we verify

NCT05216718

Mini-flap BABA (Bilateral Axillo-breast Approach) Robotic Thyroidectomy is Safe

Status unknown NA Last updated 31 January 2022
What this trial tests

NA trial testing Mini-flap in Thyroid Nodule in 80 participants. Status unknown.

Timeline
24 January 2022
Primary endpoint
31 December 2022
1 December 2023

Quick facts

Lead sponsorInje University
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposetreatment
Enrollment80
Start date24 January 2022
Primary completion31 December 2022
Estimated completion1 December 2023
Sites1 location across South Korea

Drugs / interventions tested

Conditions studied

Sponsor

Inje University

Who can join

Adults 19 to 69, any sex, with Thyroid Nodule. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In this study, a randomized controlled study was conducted between two groups of 40 recipients of conventional flap during BABA robotic-thyroidectomy and 40 recipients of Mini-flap method during BABA robotic-thyroidectomy. In this study, we tried to determine whether the use of Mini-flap can reduce sensory loss and pain after BABA robotic-thyroidectomy.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Comparison of the Postoperative Outcomes of the Mini-Flap Bilateral Axillo-Breast Approach (BABA) and Conventional BABA Robot-Assisted Thyroidectomy.
    Shin IB, Bae DS. · · 2022 · cited 5× · PMID 36013133 · DOI 10.3390/jcm11164894

Verify or expand the search:

Other recruiting trials for Thyroid Nodule

Currently open trials in the same condition.

Other Inje University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05216718.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing